PU.1/microRNA-142-3p targets ATG5/ATG16L1 to inactivate autophagy and sensitize hepatocellular carcinoma cells to sorafenib.
about
Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells.The Role of MicroRNAs in Hepatocellular CarcinomaLinc02527 promoted autophagy in Intrahepatic cholestasis of pregnancyMicroRNAs in Cardiac Autophagy: Small Molecules and Big Role
P2860
PU.1/microRNA-142-3p targets ATG5/ATG16L1 to inactivate autophagy and sensitize hepatocellular carcinoma cells to sorafenib.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
PU.1/microRNA-142-3p targets A ...... carcinoma cells to sorafenib.
@en
PU.1/microRNA-142-3p targets A ...... carcinoma cells to sorafenib.
@nl
type
label
PU.1/microRNA-142-3p targets A ...... carcinoma cells to sorafenib.
@en
PU.1/microRNA-142-3p targets A ...... carcinoma cells to sorafenib.
@nl
prefLabel
PU.1/microRNA-142-3p targets A ...... carcinoma cells to sorafenib.
@en
PU.1/microRNA-142-3p targets A ...... carcinoma cells to sorafenib.
@nl
P2093
P2860
P1476
PU.1/microRNA-142-3p targets A ...... carcinoma cells to sorafenib.
@en
P2093
Chunni Zhang
Longbang Chen
Xiaoyuan Chu
Yingru Zhi
P2860
P2888
P356
10.1038/S41419-018-0344-0
P577
2018-02-22T00:00:00Z
P6179
1101164170